Carson, W E <br/><br/>
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.  [electronic resource] 

 -  European journal of immunology  Oct 2001 
 - 3016-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0014-2980 
<br/><br/><label>Standard No.: </label>10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibody-Dependent Cell Cytotoxicity<br/>Breast Neoplasms--immunology<br/>CD56 Antigen--analysis<br/>Cytokines--biosynthesis<br/>Humans<br/>Interleukin-2--pharmacology<br/>Killer Cells, Natural--drug effects<br/>Lymphocyte Activation<br/>Mice<br/>Receptor, ErbB-2--analysis<br/>Receptors, IgG--physiology<br/>Trastuzumab<br/>Tumor Cells, Cultured